A new Android spyware named ClayRat is deceiving users by mimicking popular apps. Targeting Russian users, it steals sensitive data and propagates through compromised devices. Discover how it operates and what you can do to protect yourself!
AstraZeneca partners with the Trump administration to offer drastically lower drug prices through Medicaid and the upcoming TrumpRx platform, aiming to make medications more accessible to consumers.
The competition for smart glasses heats up as Meta releases new models, while Apple and Samsung rush to catch up. With AR technology evolving, the smart glasses market is poised for a major transformation.
Gov. Gavin Newsom signs SB 79, aiming to tackle California's housing crisis by allowing taller buildings near transit hubs. Will this ambitious plan succeed or face backlash?
In a surprising twist, Attorney General Pam Bondi and DOJ leaders were caught off guard by the indictment of NY Attorney General Letitia James. Discover the dramatic events that unfolded and the implications for political justice!
A measles outbreak in South Carolina has led to the quarantine of 153 unvaccinated children, while another outbreak is growing in Minnesota. Health experts warn of increasing community transmission as vaccination rates decline.
A new Washington Post-KFF poll reveals pediatricians are the most trusted source for vaccine information, with parents' confidence significantly influencing vaccination rates. Discover the impact of misinformation on parental decisions.
Struggling to exercise? Discover how 'exercise snacks'—short bursts of activity—can enhance your fitness and health, making it easier to stay active even with a busy lifestyle!
A groundbreaking discovery in cosmology reveals a low-mass object detected through gravitational lensing. This finding challenges our understanding of dark matter and its distribution in the universe.
In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
